General Information of Drug (ID: DMYH9BC)

Drug Name
(Z)-2-Methyl-1-oxazol-2-yl-octadec-9-en-1-one
Synonyms CHEMBL37044; (Z)-2-Methyl-1-oxazol-2-yl-octadec-9-en-1-one; BDBM50100866
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 2 Molecular Weight (mw) 347.5
Logarithm of the Partition Coefficient (xlogp) 8.4
Rotatable Bond Count (rotbonds) 16
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C22H37NO2
IUPAC Name
(Z)-2-methyl-1-(1,3-oxazol-2-yl)octadec-9-en-1-one
Canonical SMILES
CCCCCCCC/C=C\\CCCCCCC(C)C(=O)C1=NC=CO1
InChI
InChI=1S/C22H37NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(2)21(24)22-23-18-19-25-22/h10-11,18-20H,3-9,12-17H2,1-2H3/b11-10-
InChIKey
VNDQKKVLWCFNIJ-KHPPLWFESA-N
Cross-matching ID
PubChem CID
11221755
TTD ID
D0PJ3R

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fatty acid amide hydrolase (FAAH) TTDP1UC NOUNIPROTAC Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Fatty acid amide hydrolase (FAAH) DTT NO-GeName 2.65E-01 0.02 0.1
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 alpha-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and alpha-substitution. Bioorg Med Chem Lett. 2001 Jun 18;11(12):1517-20.